Jutta Haunschild

543 total citations
27 papers, 414 citations indexed

About

Jutta Haunschild is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jutta Haunschild has authored 27 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Jutta Haunschild's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Respiratory and Cough-Related Research (3 papers). Jutta Haunschild is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Respiratory and Cough-Related Research (3 papers). Jutta Haunschild collaborates with scholars based in Germany, Austria and United States. Jutta Haunschild's co-authors include Armin Saalmüller, Sigmar de Mello Rode, W. Wuttke, Una Rauchhaus, Dana Seidlová‐Wuttke, Dietmar Utesch, Nicola J. Hewitt, B. Ladstetter, Oliver Werz and Hubertus Jarry and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Jutta Haunschild

25 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jutta Haunschild Germany 12 108 91 60 58 54 27 414
Ljubinka Janković Veličković Serbia 15 205 1.9× 86 0.9× 21 0.3× 93 1.6× 72 1.3× 56 608
Sabry Shaarawy Egypt 11 146 1.4× 74 0.8× 29 0.5× 125 2.2× 21 0.4× 22 477
Sudhir Kumar Chauhan India 12 101 0.9× 70 0.8× 83 1.4× 101 1.7× 12 0.2× 22 628
Hsinyi Tsang United States 15 176 1.6× 42 0.5× 41 0.7× 36 0.6× 14 0.3× 29 596
Hyun‐Soo Shin South Korea 11 194 1.8× 77 0.8× 47 0.8× 36 0.6× 17 0.3× 19 464
Sanlan Wu China 14 139 1.3× 69 0.8× 30 0.5× 58 1.0× 20 0.4× 37 538
Yu-An Hsu Taiwan 14 202 1.9× 43 0.5× 32 0.5× 39 0.7× 118 2.2× 19 677
Min Yin China 15 167 1.5× 45 0.5× 38 0.6× 26 0.4× 32 0.6× 29 418
Yue Wan China 11 314 2.9× 72 0.8× 26 0.4× 49 0.8× 39 0.7× 22 506
Xie China 11 166 1.5× 48 0.5× 22 0.4× 110 1.9× 12 0.2× 98 540

Countries citing papers authored by Jutta Haunschild

Since Specialization
Citations

This map shows the geographic impact of Jutta Haunschild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jutta Haunschild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jutta Haunschild more than expected).

Fields of papers citing papers by Jutta Haunschild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jutta Haunschild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jutta Haunschild. The network helps show where Jutta Haunschild may publish in the future.

Co-authorship network of co-authors of Jutta Haunschild

This figure shows the co-authorship network connecting the top 25 collaborators of Jutta Haunschild. A scholar is included among the top collaborators of Jutta Haunschild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jutta Haunschild. Jutta Haunschild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiedler, Ulrike, Keith M. Dawson, Jutta Haunschild, et al.. (2018). Abstract CT149: MP0250, a VEGF- and HGF-blocking multi-DARPin drug candidate, in combination with tyrosine-kinase-inhibitors targeting EGFR-mutated NSCLC: Preclinical rationale and phase Ib/II study outline. Cancer Research. 78(13_Supplement). CT149–CT149. 1 indexed citations
2.
Azaro, Analía, Jordi Rodón, Mark R. Middleton, et al.. (2018). First-in-class phase I study evaluating MP0250, a VEGF and HGF neutralizing DARPIN molecule, in patients with advanced solid tumors.. Journal of Clinical Oncology. 36(15_suppl). 2520–2520. 7 indexed citations
3.
4.
Seibel, Jan, Carlo Pergola, Oliver Werz, et al.. (2015). Bronchipret® syrup containing thyme and ivy extracts suppresses bronchoalveolar inflammation and goblet cell hyperplasia in experimental bronchoalveolitis. Phytomedicine. 22(13). 1172–1177. 20 indexed citations
5.
Seibel, Jan, Carlo Pergola, Oliver Werz, Katja Wosikowski, & Jutta Haunschild. (2013). A combination of thyme and primula dry extracts possesses antitussive activity and inhibits leukotriene formation. European Respiratory Journal. 42(Suppl 57). P743–P743. 1 indexed citations
6.
Wuttke, W., et al.. (2013). The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa). The Journal of Steroid Biochemistry and Molecular Biology. 139. 302–310. 45 indexed citations
7.
Barthelmes, Jan, G Stecher, Daniel Intelmann, et al.. (2013). Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055. Phytomedicine. 20(14). 1306–1314. 11 indexed citations
8.
Seifert, Stephanie N., et al.. (2012). The Novel Sinupret® dry extract BNO 1011 inhibits paw oedema development in vivo and inflammatory mediator release in vitro. Planta Medica. 78(11). 1 indexed citations
9.
Rossi, Antonietta, et al.. (2012). The novel Sinupret® dry extract exhibits anti-inflammatory effectiveness in vivo. Fitoterapia. 83(4). 715–720. 29 indexed citations
10.
Seifert, Stephanie N., et al.. (2012). In vitro anti-inflammatory and anti-microbial activity of cowslip flowers (Primula veris L.). Planta Medica. 78(11). 3 indexed citations
11.
12.
Seidlová‐Wuttke, Dana, et al.. (2012). Osteoprotective effects of Cimicifuga racemosa and its triterpene-saponins are responsible for reduction of bone marrow fat. Phytomedicine. 19(10). 855–860. 25 indexed citations
13.
14.
15.
16.
Fuchs, Paul C., et al.. (2006). A recombinant anti-ICAM-1 Fab fragment is as effective as the complete IgG antibody in treatment of burns in rabbits. Burns. 32(4). 430–435. 1 indexed citations
17.
Boehncke, Wolf‐­Henning, et al.. (2005). Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse model. British Journal of Dermatology. 153(4). 758–766. 12 indexed citations
18.
Senekowitsch–Schmidtke, Reingard, et al.. (1996). In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425. Cancer Immunology Immunotherapy. 42(2). 108–114. 19 indexed citations
19.
Haunschild, Jutta, et al.. (1995). Distribution of humanized MAb 425 (EMD 62,000) in rats and specific localization in tumor-bearing nude mice.. PubMed. 41(1). 179–84. 9 indexed citations
20.
Haunschild, Jutta, et al.. (1993). Mitogenicity of anti‐Thy‐1 monoclonal antibodies attributable to an Fc‐dependent mechanism. European Journal of Immunology. 23(10). 2649–2654. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ljubinka Janković Veličković Breakdown of academic impact, for papers by Sabry Shaarawy Breakdown of academic impact, for papers by Sudhir Kumar Chauhan Breakdown of academic impact, for papers by Hsinyi Tsang Breakdown of academic impact, for papers by Hyun‐Soo Shin Breakdown of academic impact, for papers by Sanlan Wu Breakdown of academic impact, for papers by Yu-An Hsu Breakdown of academic impact, for papers by Min Yin Breakdown of academic impact, for papers by Yue Wan Breakdown of academic impact, for papers by Xie
Rankless by CCL
2026